Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Interatomic Potential for Hydrocarbons on the Basis of the Modified Embedded-Atom Method with Bond Order (MEAM-BO).

Mun S, Bowman AL, Nouranian S, Gwaltney SR, Baskes MI, Horstemeyer MF.

J Phys Chem A. 2017 Feb 23;121(7):1502-1524. doi: 10.1021/acs.jpca.6b11343. Epub 2017 Feb 13.

PMID:
28121152
2.

Phosphorylation of Src by phosphoinositide 3-kinase regulates beta-adrenergic receptor-mediated EGFR transactivation.

Watson LJ, Alexander KM, Mohan ML, Bowman AL, Mangmool S, Xiao K, Naga Prasad SV, Rockman HA.

Cell Signal. 2016 Oct;28(10):1580-92. doi: 10.1016/j.cellsig.2016.05.006. Epub 2016 May 8.

3.

Novel adamantyl cannabinoids as CB1 receptor probes.

Thakur GA, Bajaj S, Paronis C, Peng Y, Bowman AL, Barak LS, Caron MG, Parrish D, Deschamps JR, Makriyannis A.

J Med Chem. 2013 May 23;56(10):3904-21. doi: 10.1021/jm4000775. Epub 2013 May 14.

4.

Membrane phospholipid bilayer as a determinant of monoacylglycerol lipase kinetic profile and conformational repertoire.

Nasr ML, Shi X, Bowman AL, Johnson M, Zvonok N, Janero DR, Vemuri VK, Wales TE, Engen JR, Makriyannis A.

Protein Sci. 2013 Jun;22(6):774-87. doi: 10.1002/pro.2257. Epub 2013 Apr 29.

5.

Highly predictive ligand-based pharmacophore and homology models of ABHD6.

Bowman AL, Makriyannis A.

Chem Biol Drug Des. 2013 Mar;81(3):382-8. doi: 10.1111/cbdd.12086. Epub 2012 Dec 26.

6.

Sulfonyl fluoride inhibitors of fatty acid amide hydrolase.

Alapafuja SO, Nikas SP, Bharathan IT, Shukla VG, Nasr ML, Bowman AL, Zvonok N, Li J, Shi X, Engen JR, Makriyannis A.

J Med Chem. 2012 Nov 26;55(22):10074-89. doi: 10.1021/jm301205j. Epub 2012 Nov 2.

7.

Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition.

West JM, Zvonok N, Whitten KM, Vadivel SK, Bowman AL, Makriyannis A.

PLoS One. 2012;7(8):e43877. doi: 10.1371/journal.pone.0043877. Epub 2012 Aug 31.

8.

C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor.

Dixon DD, Tius MA, Thakur GA, Zhou H, Bowman AL, Shukla VG, Peng Y, Makriyannis A.

Bioorg Med Chem Lett. 2012 Aug 15;22(16):5322-5. doi: 10.1016/j.bmcl.2012.06.013. Epub 2012 Jun 15.

9.

Approximating protein flexibility through dynamic pharmacophore models: application to fatty acid amide hydrolase (FAAH).

Bowman AL, Makriyannis A.

J Chem Inf Model. 2011 Dec 27;51(12):3247-53. doi: 10.1021/ci200371z. Epub 2011 Dec 7.

10.

Novel 1',1'-chain substituted hexahydrocannabinols: 9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid receptor 1 (CB1) agonist.

Nikas SP, Alapafuja SO, Papanastasiou I, Paronis CA, Shukla VG, Papahatjis DP, Bowman AL, Halikhedkar A, Han X, Makriyannis A.

J Med Chem. 2010 Oct 14;53(19):6996-7010. doi: 10.1021/jm100641g.

11.

Quantitative, label-free detection of five protein biomarkers using multiplexed arrays of silicon photonic microring resonators.

Washburn AL, Luchansky MS, Bowman AL, Bailey RC.

Anal Chem. 2010 Jan 1;82(1):69-72. doi: 10.1021/ac902451b.

12.

Muscle giants: molecular scaffolds in sarcomerogenesis.

Kontrogianni-Konstantopoulos A, Ackermann MA, Bowman AL, Yap SV, Bloch RJ.

Physiol Rev. 2009 Oct;89(4):1217-67. doi: 10.1152/physrev.00017.2009. Review.

13.

The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle.

Ford-Speelman DL, Roche JA, Bowman AL, Bloch RJ.

Mol Biol Cell. 2009 Sep;20(17):3905-17. doi: 10.1091/mbc.E08-10-1029. Epub 2009 Jul 15.

14.

Refined homology model of monoacylglycerol lipase: toward a selective inhibitor.

Bowman AL, Makriyannis A.

J Comput Aided Mol Des. 2009 Nov;23(11):799-806. doi: 10.1007/s10822-009-9289-9. Epub 2009 Jun 20.

15.

Obscurin interacts with a novel isoform of MyBP-C slow at the periphery of the sarcomeric M-band and regulates thick filament assembly.

Ackermann MA, Hu LY, Bowman AL, Bloch RJ, Kontrogianni-Konstantopoulos A.

Mol Biol Cell. 2009 Jun;20(12):2963-78. doi: 10.1091/mbc.E08-12-1251. Epub 2009 Apr 29.

16.

Solid-state NMR and molecular dynamics characterization of cannabinoid receptor-1 (CB1) helix 7 conformational plasticity in model membranes.

Tiburu EK, Bowman AL, Struppe JO, Janero DR, Avraham HK, Makriyannis A.

Biochim Biophys Acta. 2009 May;1788(5):1159-67. doi: 10.1016/j.bbamem.2009.02.002. Epub 2009 Feb 12.

17.

Bornyl- and isobornyl-Delta8-tetrahydrocannabinols: a novel class of cannabinergic ligands.

Lu D, Guo J, Duclos RI Jr, Bowman AL, Makriyannis A.

J Med Chem. 2008 Oct 23;51(20):6393-9. doi: 10.1021/jm8005299. Epub 2008 Oct 1.

18.

QM/MM simulations predict a covalent intermediate in the hen egg white lysozyme reaction with its natural substrate.

Bowman AL, Grant IM, Mulholland AJ.

Chem Commun (Camb). 2008 Oct 7;(37):4425-7. doi: 10.1039/b810099c. Epub 2008 Aug 5.

PMID:
18802578
19.

Development of novel tail-modified anandamide analogs.

Yao F, Li C, Vadivel SK, Bowman AL, Makriyannis A.

Bioorg Med Chem Lett. 2008 Nov 15;18(22):5912-5. doi: 10.1016/j.bmcl.2008.07.110. Epub 2008 Jul 31.

20.

The rho-guanine nucleotide exchange factor domain of obscurin regulates assembly of titin at the Z-disk through interactions with Ran binding protein 9.

Bowman AL, Catino DH, Strong JC, Randall WR, Kontrogianni-Konstantopoulos A, Bloch RJ.

Mol Biol Cell. 2008 Sep;19(9):3782-92. doi: 10.1091/mbc.E08-03-0237. Epub 2008 Jun 25.

Supplemental Content

Loading ...
Support Center